Michael Mansfield

2.9k total citations
52 papers, 2.1k citations indexed

About

Michael Mansfield is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Hematology. According to data from OpenAlex, Michael Mansfield has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 21 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Hematology. Recurrent topics in Michael Mansfield's work include Blood properties and coagulation (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Adipokines, Inflammation, and Metabolic Diseases (9 papers). Michael Mansfield is often cited by papers focused on Blood properties and coagulation (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Adipokines, Inflammation, and Metabolic Diseases (9 papers). Michael Mansfield collaborates with scholars based in United Kingdom, Germany and France. Michael Mansfield's co-authors include Peter J. Grant, Max H. Stickland, Robert A.S. Ariëns, Andrew J. Catto, H Köhler, Joseph Mills, Louise Dye, Jennifer H. Barrett, Mark S. Freeman and Clare Lawton and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Mansfield

52 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Mansfield United Kingdom 24 732 664 487 468 463 52 2.1k
Jan Feyzi United States 13 1.1k 1.5× 139 0.2× 325 0.7× 306 0.7× 208 0.4× 15 2.4k
Harinder S. Juneja United States 16 494 0.7× 198 0.3× 348 0.7× 103 0.2× 217 0.5× 54 1.3k
Jennifer Johns Australia 19 253 0.3× 337 0.5× 1.7k 3.6× 238 0.5× 178 0.4× 40 2.6k
Pilar Chacón Spain 24 113 0.2× 624 0.9× 376 0.8× 208 0.4× 879 1.9× 52 2.0k
Dimitrios Stakos Greece 27 169 0.2× 293 0.4× 825 1.7× 117 0.3× 316 0.7× 76 2.2k
J.K. Radder Netherlands 19 150 0.2× 144 0.2× 436 0.9× 453 1.0× 231 0.5× 34 1.4k
Yu‐Lin Ko Taiwan 24 79 0.1× 330 0.5× 794 1.6× 560 1.2× 509 1.1× 133 2.3k
V. Manger Cats Netherlands 16 405 0.6× 284 0.4× 1.1k 2.4× 126 0.3× 125 0.3× 49 1.8k
Bradley S. Jacobs United States 13 73 0.1× 472 0.7× 467 1.0× 146 0.3× 682 1.5× 22 1.6k
Michelangelo Sartori Italy 23 190 0.3× 174 0.3× 639 1.3× 292 0.6× 215 0.5× 87 1.7k

Countries citing papers authored by Michael Mansfield

Since Specialization
Citations

This map shows the geographic impact of Michael Mansfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mansfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mansfield more than expected).

Fields of papers citing papers by Michael Mansfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mansfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mansfield. The network helps show where Michael Mansfield may publish in the future.

Co-authorship network of co-authors of Michael Mansfield

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Mansfield. A scholar is included among the top collaborators of Michael Mansfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Mansfield. Michael Mansfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Downie, Paul, Natalie Forrester, Anthony S. Wierzbicki, et al.. (2024). Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry. Arteriosclerosis Thrombosis and Vascular Biology. 44(11). 2334–2346. 8 indexed citations
2.
Traviss‐Turner, Gemma, Andrew P. Hill, Suzanne Heywood‐Everett, et al.. (2024). Providing Online guided Self-help for the management of binge Eating in adults with type 2 Diabetes: The POSE-D pilot study and process evaluation. British Journal Of Nutrition. 132(11). 1542–1552. 1 indexed citations
3.
Bashir, Babar, See Kwok, Anthony S. Wierzbicki, et al.. (2023). Familial Chylomicronaemia Syndrome (FCS) Compared to Multifactorial Chylomicronaemia Syndrome (MCS) – Lessons learnt from United Kingdom FCS Registry. SHILAP Revista de lepidopterología. 54. S4–S4. 1 indexed citations
4.
Ho, Jan Hoong, Paul Hamilton, Gordon A. Ferns, et al.. (2023). Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options. Metabolites. 13(5). 621–621. 22 indexed citations
5.
Hill, Andrew J., et al.. (2023). Adapting an online guided self‐help intervention for the management of binge eating in adults with type 2 diabetes: The POSE‐D study. Diabetic Medicine. 40(8). e15082–e15082. 3 indexed citations
6.
Jones, Alan, Anthony S. Wierzbicki, Radha Ramachandran, et al.. (2023). Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS). Atherosclerosis. 375. 67–74. 27 indexed citations
7.
Bashir, Babar, See Kwok, Anthony S. Wierzbicki, et al.. (2023). Natural history of familial chylomicronaemia syndrome (FCS) compared to multifactorial chylomicronaemia syndrome (MCS) - Initial analysis from united kingdom fcs registry. Atherosclerosis. 379. S4–S4. 1 indexed citations
8.
Khatib, Rani, et al.. (2022). Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors. Open Heart. 9(1). e001931–e001931. 9 indexed citations
9.
Abbott, Janice, M. A. Hurley, Louise Dye, et al.. (2021). Cystic fibrosis-related diabetes (CFRD) and cognitive function in adults with cystic fibrosis. Journal of Cystic Fibrosis. 21(3). 519–528. 7 indexed citations
10.
Lamport, Daniel J., et al.. (2014). A low glycaemic load breakfast can attenuate cognitive impairments observed in middle aged obese females with impaired glucose tolerance. Nutrition Metabolism and Cardiovascular Diseases. 24(10). 1128–1136. 11 indexed citations
11.
12.
Carter, A. M., Katherine K. Anagnostopoulou, Michael Mansfield, & Peter J. Grant. (2003). Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease. Journal of Thrombosis and Haemostasis. 1(8). 1718–1723. 51 indexed citations
13.
Köhler, H, Robert A.S. Ariëns, Andrew J. Catto, et al.. (2002). Factor XIII A‐subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle‐aged men. British Journal of Haematology. 118(3). 825–832. 19 indexed citations
14.
Catto, Andrew J., L. J. McCormack, Michael Mansfield, et al.. (2000). Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurologica Scandinavica. 101(6). 399–404. 47 indexed citations
15.
Mansfield, Michael, et al.. (1998). Polymorphisms of platelet glycoproteins in relation to macrovascular disease in Type 2 diabetes mellitus. Diabetic Medicine. 15(4). 315–319. 9 indexed citations
16.
Mansfield, Michael, et al.. (1998). Fibrinolytic measurements in Type 2 diabetic patients with acute cerebral infarction. Diabetic Medicine. 15(11). 953–957. 8 indexed citations
17.
18.
Ossei‐Gerning, Nicholas, Michael Mansfield, Max H. Stickland, & Peter J. Grant. (1997). Insulin receptor substrate-1 gene polymorphism and cardiovascular risk in non-insulin dependent diabetes mellitus and patients undergoing coronary angiography. Clinical & Laboratory Haematology. 19(2). 123–128. 10 indexed citations
19.
McCormack, L. J., Dinesh Nagi, Max H. Stickland, et al.. (1996). Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome. Diabetologia. 39(12). 1512–1518. 30 indexed citations
20.
Nagi, Dinesh, Michael Mansfield, Max H. Stickland, & Peter J. Grant. (1995). Angiotensin Converting Enzyme (ACE) Insertion/Deletion (I/D) Polymorphism, and Diabetic Retinopathy in Subjects with IDDM and NIDDM. Diabetic Medicine. 12(11). 997–1001. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Feyzi Breakdown of academic impact, for papers by Harinder S. Juneja Breakdown of academic impact, for papers by Jennifer Johns Breakdown of academic impact, for papers by Pilar Chacón Breakdown of academic impact, for papers by Dimitrios Stakos Breakdown of academic impact, for papers by J.K. Radder Breakdown of academic impact, for papers by Yu‐Lin Ko Breakdown of academic impact, for papers by V. Manger Cats Breakdown of academic impact, for papers by Bradley S. Jacobs Breakdown of academic impact, for papers by Michelangelo Sartori
Rankless by CCL
2026